Radiopharmaceutical Validation for Clinical Use

Radiopharmaceuticals are reemerging as attractive anticancer agents, but there are no universally adopted guidelines or standardized procedures for evaluating agent validity before early-phase trial implementation. To validate a radiopharmaceutical, it is desirous for the radiopharmaceutical to be s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Oncol
Glavni autori: Kunos, Charles A., Howells, Rodney, Chauhan, Aman, Myint, Zin W., Bernard, Mark E., El Khouli, Riham, Capala, Jacek
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7966985/
https://ncbi.nlm.nih.gov/pubmed/33747951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.630827
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items